- Telehealth Visits
- Insurance plan information
Lily Kornbluth, MD
Internal Medicine- Telehealth Visits
- Insurance plan information
Lily Kornbluth, MD
Internal Medicine- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Lily Kornbluth is an internal medicine specialist who provides primary and urgent care for adults.
Kornbluth earned her medical degree at the David Geffen School of Medicine at UCLA. She completed a residency in internal medicine at UCSF.
Education & training
Board certification
- Internal Medicine, American Board of Internal Medicine
Residency
- Internal Medicine, UCSF Graduate Medical Education
Internship
- Internal Medicine, UCSF Medical Center - OMAG
Degree
- MD, UCLA David Geffen School of Medicine
My expertise
Specialties
Clinical Trials query: q=health_gateway_id_ss%3A%28%222635%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222635%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 36 reviews
- September 26, 20250 out of 5 Stars
Not seeking care, but intro meeting with Dr. Kornbluth was great and thorough for my wife and me.
- September 21, 20255 out of 5 Stars
It was the first time I'd met with this primary care doctor. It was confidence inspiring.
- September 19, 20255 out of 5 Stars
Outstanding clinician. Encyclopedic knowledge of medical literature across a panoply of disciplines and sub disciplines. Accomplished harp player.
- September 16, 20255 out of 5 Stars
Above & Beyond Dr Kornbluth Conerns that I received!!
- August 22, 20255 out of 5 Stars
She is GREAT!
- August 8, 20255 out of 5 Stars
Love her!
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.